Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
McKesson
Cipla
Moodys
Colorcon
Merck
AstraZeneca
Chinese Patent Office
Chubb

Generated: January 17, 2018

DrugPatentWatch Database Preview

Sun Pharm Inds Inc Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS INC, and what generic alternatives to SUN PHARM INDS INC drugs are available?

SUN PHARM INDS INC has seventy-one approved drugs.

There are five US patents protecting SUN PHARM INDS INC drugs and there have been two Paragraph IV challenges on SUN PHARM INDS INC drugs in the past three years. There is one tentative approval on SUN PHARM INDS INC drugs.

There are ten patent family members on SUN PHARM INDS INC drugs in eight countries and seventy-three supplementary protection certificates in thirteen countries.

Summary for Sun Pharm Inds Inc
International Patents:10
US Patents:5
Tradenames:63
Ingredients:60
NDAs:71

Drugs and US Patents for Sun Pharm Inds Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 090535-002 Dec 26, 2013 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc ATENOLOL atenolol TABLET;ORAL 078210-001 Jul 10, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc HALOG halcinonide SOLUTION;TOPICAL 017823-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078627-002 Jun 13, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 077631-002 Jan 11, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 077620-002 Jan 11, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc ATENOLOL atenolol TABLET;ORAL 078210-002 Jul 10, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc RISPERIDONE risperidone TABLET;ORAL 078036-005 Mar 10, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc RISPERIDONE risperidone TABLET;ORAL 078036-002 Mar 10, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc ABSORICA isotretinoin CAPSULE;ORAL 021951-005 Aug 15, 2014 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Sun Pharm Inds Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Inc BACTRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 018374-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc BACTRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 018374-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc EXELDERM sulconazole nitrate SOLUTION;TOPICAL 018738-001 Aug 30, 1985 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for SUN PHARM INDS INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 25 mg ➤ Subscribe 5/16/2016
➤ Subscribe Capsules 35 mg ➤ Subscribe 11/25/2015
➤ Subscribe Capsules 20 mg ➤ Subscribe 6/19/2013
➤ Subscribe Capsules 20 mg ➤ Subscribe 1/7/2013
➤ Subscribe Capsules 30 mg and 40 mg ➤ Subscribe 12/31/2012

International Patents for Sun Pharm Inds Inc Drugs

Supplementary Protection Certificates for Sun Pharm Inds Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0033 France ➤ Subscribe PRODUCT NAME: ALISKIRENE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE E CELUI-CI, AMLODIPINE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, ET HYDROCHLOROTHIAZIDE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; NAT. REGISTRATION NO/DATE: EU/1/11/730/001 20111122; FIRST REGISTRATION: 6167801 20110705
C/GB04/012 United Kingdom ➤ Subscribe PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
330 Luxembourg ➤ Subscribe CERTIFICATE TITLE: UNE COMBINAISON D'OLMESARTAN MEDOXOMIL, OPTIONNELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE ET D'HYDROCHLOROTHIAZIDE (OLMETEC PLUS)
C0009 Belgium ➤ Subscribe PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015
1506211/02 Switzerland ➤ Subscribe PRODUCT NAME: DAPAGLIFLOZIN + METFORMIN; REGISTRATION NO/DATE: SWISSMEDIC 65377 16.07.2015
2014026,C1506211 Lithuania ➤ Subscribe PRODUCT NAME: DAPAGLIFLOZINUM + METFORMINUM; REGISTRATION NO/DATE: EU/1/13/900 20140116
C/GB08/040 United Kingdom ➤ Subscribe PRODUCT NAME: SITAGLIPTIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR THE MONOPHOSPHATE, PLUS METFORMIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR THE HYDROCHLORIDE.; REGISTERED: CH 58450 01-03 20080408; UK EU/1/08/455/001 20080716; UK EU/1/08/455/002 20080716; UK EU/1/08/455/003 20080716; UK EU/1/08/455/004 20080716; UK EU/1/08/455/005 20080716; UK EU/1/08/455/006 20080716; UK EU/1/08/455/007 20080716; UK EU/1/08/455/008 20080716; UK EU/1/08/455/009 20080716; UK EU/1/08/455/010 20080716; UK EU/1/08/455/011 20080716; UK EU/1/08/455/012 20080716; UK EU/1/08/455/013 20080716; UK EU/1/08/455/014 20080716
2014026 Lithuania ➤ Subscribe PRODUCT NAME: DAPAGLIFOZINUM + METFORMINUM; REGISTRATION NO/DATE: EU/1/13/900 20140116
C0028 France ➤ Subscribe PRODUCT NAME: ASSOCIATION COMPRENANT LA SAXAGLIPTINE OU UN DE SES SELS ET LA METFORMINE OU UN DE SES SELS, Y COMPRIS L'ASSOCIATION CHLORHYDRATE DE SAXAGLIPTINE ET CHLORHYDRATE DE METFORMINE; REGISTRATION NO/DATE: EU/1/11/731/001 20111124
00499 Netherlands ➤ Subscribe PRODUCT NAME: COMBINATIE OMVATTEND ALISKIREN OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110114
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Cerilliant
Farmers Insurance
Healthtrust
Fuji
McKesson
Accenture
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot